Rosa S Schnaiderman

Title: Rosa S Schnaiderman: Innovator in Cancer Treatment

Introduction

Rosa S Schnaiderman is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on improving the efficacy of cancer therapies, particularly in the treatment of hepatocellular carcinoma.

Latest Patents

Rosa holds a patent titled "Methods and compositions for treating tumors with TTFields and sorafenib." This patent describes a method where the viability of cancer cells can be reduced by administering sorafenib and applying an alternating electric field with a frequency between 100 and 400 kHz. The experiments conducted demonstrate that this combination produces synergistic results both in vitro and in vivo, showcasing the potential for enhanced cancer treatment strategies.

Career Highlights

Rosa is associated with Novocure GmbH, a company known for its innovative approaches to cancer treatment. Her work at Novocure has been instrumental in advancing the understanding and application of tumor treatment methodologies. With her expertise, she continues to contribute to the development of effective cancer therapies.

Collaborations

Rosa collaborates with notable colleagues, including Karnit Gotlib and Einav Zeevi. These partnerships enhance the research efforts and foster innovation in the field of cancer treatment.

Conclusion

Rosa S Schnaiderman's contributions to cancer treatment through her patented methods highlight her role as a leading inventor in the medical field. Her innovative approaches have the potential to significantly impact the lives of patients suffering from cancer.